Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
about
Nephroprotective effect of heparanase in experimental nephrotic syndromeDeterioration of glomerular endothelial surface layer induced by oxidative stress is implicated in altered permeability of macromolecules in Zucker fatty rats.Heparanase levels are elevated in the urine and plasma of type 2 diabetes patients and associate with blood glucose levelsAngiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathyEndothelial Nitric Oxide Synthase Prevents Heparanase Induction and the Development of Proteinuria.Heparanase in inflammation and inflammation-associated cancer.The role of heparanase and the endothelial glycocalyx in the development of proteinuria.The endothelium in diabetic nephropathy.Renin-angiotensin system within the diabetic podocyte.Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression.Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.Reactive oxygen species mediate high glucose-induced heparanase-1 production and heparan sulphate proteoglycan degradation in human and rat endothelial cells: a potential role in the pathogenesis of atherosclerosis.Endothelin-1 Induces Proteinuria by Heparanase-Mediated Disruption of the Glomerular Glycocalyx.Vitamin D attenuates proteinuria by inhibition of heparanase expression in the podocyte.Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.Heparanase Inhibition Reduces Glucose Levels, Blood Pressure, and Oxidative Stress in Apolipoprotein E Knockout Mice.Xiao-Shen-Formula, a Traditional Chinese Medicine, Improves Glomerular Hyper-Filtration in Diabetic Nephropathy via Inhibiting Arginase Activation and Heparanase Expression
P2860
Q27312011-B2B00EF3-AC9B-4CFB-B4C1-E1D1FA4D498DQ30495718-D6C2DF83-4636-4CE2-9DA5-91E7F95E1496Q33834001-416E5FEF-FE19-4CDE-A953-267D6038A20DQ35235668-D9FD0322-1E55-4DAE-8E70-D0B8D1DB1C55Q35239936-5EAE7F74-44E9-4360-9C32-47F0017C6676Q36098881-5B17E995-0A82-4FFE-8C19-AF422911D6A1Q38080632-20EA7B01-7770-4BAB-9AA6-2DF980BF2C85Q38156098-AFA41FD0-C51B-4DFD-8783-F00F2B631D9AQ38195528-B0430740-64F4-4CD3-BB96-531310584F14Q38262105-B32A94B9-61DE-4046-9BA8-B1AB898F4F18Q38661556-9E2866F8-151B-495F-95E9-288C7F39C099Q39120713-D342F73C-FF1B-4A9C-9507-5FDE1E82D089Q39572643-EA81FFA8-0496-4A20-9BB8-B91DBC582F4BQ39879255-DA5998EE-0379-4A8C-B10A-025B2ED2C03EQ40706221-8DD6A79F-B5C0-47CD-8853-9377376AB8F0Q41855773-2BB6470D-DE46-4CA2-9973-CB9428B02FD3Q46068605-5D104D18-9E15-4EE1-A596-80E116D937F1Q57491629-77427661-FB51-4B9A-9C8D-A7935D208D61
P2860
Regulation of glomerular heparanase expression by aldosterone, angiotensin II and reactive oxygen species.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Regulation of glomerular hepar ...... I and reactive oxygen species.
@en
Regulation of glomerular hepar ...... I and reactive oxygen species.
@nl
type
label
Regulation of glomerular hepar ...... I and reactive oxygen species.
@en
Regulation of glomerular hepar ...... I and reactive oxygen species.
@nl
prefLabel
Regulation of glomerular hepar ...... I and reactive oxygen species.
@en
Regulation of glomerular hepar ...... I and reactive oxygen species.
@nl
P2093
P2860
P356
P1476
Regulation of glomerular hepar ...... II and reactive oxygen species
@en
P2093
Andrea B Kramer
Angelique L Rops
Femke Waanders
Gerjan Navis
Harry van Goor
Jo H Berden
Mabel J van den Hoven
P2860
P304
P356
10.1093/NDT/GFP182
P407
P577
2009-05-09T00:00:00Z